STOCK TITAN

[Form 4] SLM Corporation Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

SLM Corporation (ticker: SLM) filed a Form 4 detailing an insider equity grant. On 06/17/2025 independent director Christopher T. Leech received 5,281 shares of restricted common stock at a stated price of $0 under the 2025 Independent Director Restricted Stock Agreement, part of the company’s 2021 Omnibus Incentive Plan. The award represents a portion of the annual cash retainer paid to outside directors and will vest according to the plan’s terms. No shares were sold and no derivatives were involved. After the transaction, Leech’s direct beneficial ownership rose to 12,480.9277 shares, a figure that includes dividend-equivalent units. The filing was signed on 06/20/2025 and does not reference a Rule 10b5-1 trading plan, suggesting a routine, compensation-related grant rather than an open-market purchase or sale.

SLM Corporation (simbolo: SLM) ha presentato un Modulo 4 relativo a una concessione di azioni da parte di un insider. Il 17/06/2025 il direttore indipendente Christopher T. Leech ha ricevuto 5.281 azioni di azioni ordinarie ristrette a un prezzo nominale di 0 dollari, nell'ambito dell'Accordo sulle Azioni Ristrette per Direttori Indipendenti 2025, parte del Piano Incentivi Omnibus 2021 della società. Il premio rappresenta una parte del compenso annuale in contanti destinato ai direttori esterni e maturerà secondo i termini del piano. Non sono state vendute azioni né coinvolti strumenti derivati. Dopo la transazione, la proprietà diretta di Leech è salita a 12.480,9277 azioni, cifra che include unità equivalenti ai dividendi. Il documento è stato firmato il 20/06/2025 e non fa riferimento a un piano di trading secondo la Regola 10b5-1, suggerendo che si tratti di una concessione ordinaria legata alla compensazione piuttosto che di un acquisto o vendita sul mercato aperto.

SLM Corporation (símbolo: SLM) presentó un Formulario 4 detallando una concesión de acciones internas. El 17/06/2025, el director independiente Christopher T. Leech recibió 5.281 acciones restringidas ordinarias a un precio declarado de 0 dólares bajo el Acuerdo de Acciones Restringidas para Directores Independientes 2025, parte del Plan de Incentivos Omnibus 2021 de la compañía. La concesión representa una parte de la remuneración anual en efectivo pagada a los directores externos y se consolidará según los términos del plan. No se vendieron acciones ni se involucraron derivados. Tras la transacción, la propiedad directa beneficiosa de Leech aumentó a 12.480,9277 acciones, cifra que incluye unidades equivalentes a dividendos. El documento fue firmado el 20/06/2025 y no hace referencia a un plan de negociación bajo la Regla 10b5-1, lo que sugiere que se trata de una concesión rutinaria relacionada con la compensación y no una compra o venta en el mercado abierto.

SLM 코퍼레이션(티커: SLM)은 내부자 지분 부여에 관한 양식 4를 제출했습니다. 2025년 6월 17일, 독립 이사 크리스토퍼 T. 리치는 2025년 독립 이사 제한 주식 계약에 따라 명시가격 0달러로 5,281주의 제한 보통주를 받았습니다. 이 계약은 회사의 2021년 옴니버스 인센티브 플랜의 일부입니다. 이 보상은 외부 이사에게 지급되는 연간 현금 보수의 일부를 대표하며, 플랜 조건에 따라 권리가 확정됩니다. 주식 매도나 파생상품 거래는 없었습니다. 거래 후 리치의 직접적 실질 소유 주식은 배당금 등가 단위를 포함하여 12,480.9277주로 증가했습니다. 해당 서류는 2025년 6월 20일에 서명되었으며, 10b5-1 규칙에 따른 거래 계획은 언급되지 않아 공개 시장에서의 매매가 아닌 보상 관련 일상적인 부여임을 시사합니다.

SLM Corporation (symbole : SLM) a déposé un formulaire 4 détaillant une attribution d’actions par un initié. Le 17/06/2025, le directeur indépendant Christopher T. Leech a reçu 5 281 actions ordinaires restreintes à un prix indiqué de 0 $ dans le cadre de l’Accord sur les actions restreintes des directeurs indépendants 2025, faisant partie du Plan d’incitation omnibus 2021 de la société. Cette attribution représente une partie de la rémunération annuelle en espèces versée aux administrateurs externes et sera acquise selon les termes du plan. Aucune action n’a été vendue et aucun produit dérivé n’a été impliqué. Après la transaction, la propriété bénéficiaire directe de Leech est passée à 12 480,9277 actions, un chiffre qui inclut les unités équivalentes aux dividendes. Le dépôt a été signé le 20/06/2025 et ne fait pas référence à un plan de négociation selon la règle 10b5-1, ce qui suggère une attribution de routine liée à la rémunération plutôt qu’un achat ou une vente sur le marché ouvert.

SLM Corporation (Ticker: SLM) reichte ein Formular 4 ein, das eine Insider-Aktienzuteilung detailliert. Am 17.06.2025 erhielt der unabhängige Direktor Christopher T. Leech 5.281 Aktien von eingeschränktem Stammaktienkapital zu einem angegebenen Preis von 0 USD im Rahmen des 2025 Independent Director Restricted Stock Agreement, welches Teil des Omnibus Incentive Plans 2021 des Unternehmens ist. Die Zuteilung stellt einen Teil der jährlichen Barvergütung für externe Direktoren dar und wird gemäß den Bedingungen des Plans vesten. Es wurden keine Aktien verkauft und keine Derivate eingesetzt. Nach der Transaktion erhöhte sich Leechs direkte wirtschaftliche Eigentümerschaft auf 12.480,9277 Aktien, eine Zahl, die dividendenäquivalente Einheiten einschließt. Die Einreichung wurde am 20.06.2025 unterzeichnet und verweist nicht auf einen Handelsplan gemäß Regel 10b5-1, was auf eine routinemäßige, vergütungsbezogene Zuteilung und nicht auf einen Kauf oder Verkauf am offenen Markt hindeutet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine director grant; immaterial to valuation or liquidity.

The 5,281 restricted shares awarded to Director Leech add roughly US$ (market value depends on prevailing price), a negligible amount relative to SLM’s ~US$4 bn market cap. Because the shares were issued at $0 as compensation rather than purchased, there is no immediate cash signal from the insider. The total post-grant holding of 12,481 shares is modest, so the filing does not materially change insider ownership trends or float. Investors typically view such grants as neutral unless accompanied by open-market buying or sizable accumulation, which is not the case here.

TL;DR: Standard equity retainer aligns director with shareholders; governance-neutral.

The transaction reflects SLM’s practice of paying part of the independent directors’ compensation in equity, consistent with governance best practices that foster alignment. The use of restricted stock, vesting under the 2025 Agreement, encourages longer-term orientation. Proper Section 16 reporting, timely filing (within two business days), and the absence of derivative complexity indicate strong compliance. No red flags on disclosure, timing, or structure are evident.

SLM Corporation (simbolo: SLM) ha presentato un Modulo 4 relativo a una concessione di azioni da parte di un insider. Il 17/06/2025 il direttore indipendente Christopher T. Leech ha ricevuto 5.281 azioni di azioni ordinarie ristrette a un prezzo nominale di 0 dollari, nell'ambito dell'Accordo sulle Azioni Ristrette per Direttori Indipendenti 2025, parte del Piano Incentivi Omnibus 2021 della società. Il premio rappresenta una parte del compenso annuale in contanti destinato ai direttori esterni e maturerà secondo i termini del piano. Non sono state vendute azioni né coinvolti strumenti derivati. Dopo la transazione, la proprietà diretta di Leech è salita a 12.480,9277 azioni, cifra che include unità equivalenti ai dividendi. Il documento è stato firmato il 20/06/2025 e non fa riferimento a un piano di trading secondo la Regola 10b5-1, suggerendo che si tratti di una concessione ordinaria legata alla compensazione piuttosto che di un acquisto o vendita sul mercato aperto.

SLM Corporation (símbolo: SLM) presentó un Formulario 4 detallando una concesión de acciones internas. El 17/06/2025, el director independiente Christopher T. Leech recibió 5.281 acciones restringidas ordinarias a un precio declarado de 0 dólares bajo el Acuerdo de Acciones Restringidas para Directores Independientes 2025, parte del Plan de Incentivos Omnibus 2021 de la compañía. La concesión representa una parte de la remuneración anual en efectivo pagada a los directores externos y se consolidará según los términos del plan. No se vendieron acciones ni se involucraron derivados. Tras la transacción, la propiedad directa beneficiosa de Leech aumentó a 12.480,9277 acciones, cifra que incluye unidades equivalentes a dividendos. El documento fue firmado el 20/06/2025 y no hace referencia a un plan de negociación bajo la Regla 10b5-1, lo que sugiere que se trata de una concesión rutinaria relacionada con la compensación y no una compra o venta en el mercado abierto.

SLM 코퍼레이션(티커: SLM)은 내부자 지분 부여에 관한 양식 4를 제출했습니다. 2025년 6월 17일, 독립 이사 크리스토퍼 T. 리치는 2025년 독립 이사 제한 주식 계약에 따라 명시가격 0달러로 5,281주의 제한 보통주를 받았습니다. 이 계약은 회사의 2021년 옴니버스 인센티브 플랜의 일부입니다. 이 보상은 외부 이사에게 지급되는 연간 현금 보수의 일부를 대표하며, 플랜 조건에 따라 권리가 확정됩니다. 주식 매도나 파생상품 거래는 없었습니다. 거래 후 리치의 직접적 실질 소유 주식은 배당금 등가 단위를 포함하여 12,480.9277주로 증가했습니다. 해당 서류는 2025년 6월 20일에 서명되었으며, 10b5-1 규칙에 따른 거래 계획은 언급되지 않아 공개 시장에서의 매매가 아닌 보상 관련 일상적인 부여임을 시사합니다.

SLM Corporation (symbole : SLM) a déposé un formulaire 4 détaillant une attribution d’actions par un initié. Le 17/06/2025, le directeur indépendant Christopher T. Leech a reçu 5 281 actions ordinaires restreintes à un prix indiqué de 0 $ dans le cadre de l’Accord sur les actions restreintes des directeurs indépendants 2025, faisant partie du Plan d’incitation omnibus 2021 de la société. Cette attribution représente une partie de la rémunération annuelle en espèces versée aux administrateurs externes et sera acquise selon les termes du plan. Aucune action n’a été vendue et aucun produit dérivé n’a été impliqué. Après la transaction, la propriété bénéficiaire directe de Leech est passée à 12 480,9277 actions, un chiffre qui inclut les unités équivalentes aux dividendes. Le dépôt a été signé le 20/06/2025 et ne fait pas référence à un plan de négociation selon la règle 10b5-1, ce qui suggère une attribution de routine liée à la rémunération plutôt qu’un achat ou une vente sur le marché ouvert.

SLM Corporation (Ticker: SLM) reichte ein Formular 4 ein, das eine Insider-Aktienzuteilung detailliert. Am 17.06.2025 erhielt der unabhängige Direktor Christopher T. Leech 5.281 Aktien von eingeschränktem Stammaktienkapital zu einem angegebenen Preis von 0 USD im Rahmen des 2025 Independent Director Restricted Stock Agreement, welches Teil des Omnibus Incentive Plans 2021 des Unternehmens ist. Die Zuteilung stellt einen Teil der jährlichen Barvergütung für externe Direktoren dar und wird gemäß den Bedingungen des Plans vesten. Es wurden keine Aktien verkauft und keine Derivate eingesetzt. Nach der Transaktion erhöhte sich Leechs direkte wirtschaftliche Eigentümerschaft auf 12.480,9277 Aktien, eine Zahl, die dividendenäquivalente Einheiten einschließt. Die Einreichung wurde am 20.06.2025 unterzeichnet und verweist nicht auf einen Handelsplan gemäß Regel 10b5-1, was auf eine routinemäßige, vergütungsbezogene Zuteilung und nicht auf einen Kauf oder Verkauf am offenen Markt hindeutet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Leech Christopher T.

(Last) (First) (Middle)
300 CONTINENTAL DRIVE

(Street)
NEWARK DE 19713

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SLM Corp [ SLM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/17/2025 A 5,281(1) A $0 12,480.9277(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reporting person received shares of Restricted Common Stock, issued pursuant to the terms of the SLM Corporation 2021 Omnibus Incentive Plan - 2025 Independent Director Restricted Stock Agreement (the "2025 Agreement") in partial payment of the annual retainer to independent directors. The Restricted Common Stock award is subject to vesting upon the terms set forth in the 2025 Agreement.
2. Includes Dividend Equivalent Units issued in connection with Restricted Common Stock held by the reporting person.
Remarks:
/s/ Jeffrey Lipschutz (POA) for Christopher T. Leech 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did SLM (SLM) report on the June 20 2025 Form 4?

SLM disclosed that Director Christopher T. Leech received 5,281 restricted common shares as part of his annual board retainer.

How many SLM shares does Christopher Leech own after the transaction?

Following the grant, Leech directly owns 12,480.9277 shares, including dividend-equivalent units.

Was the 5,281-share transaction a purchase or compensation grant?

It was a compensation-related grant issued at $0 per share under the 2025 Independent Director Restricted Stock Agreement.

Did the Form 4 report any sales or derivative transactions?

No. The filing shows only an acquisition of restricted stock; no shares were sold and no derivatives were involved.

Does the filing mention a Rule 10b5-1 trading plan?

The box indicating a 10b5-1 plan is unchecked, so the grant was not made under such a plan.
Slm Corp

NASDAQ:SLM

SLM Rankings

SLM Latest News

SLM Latest SEC Filings

SLM Stock Data

6.91B
207.80M
1.17%
104.54%
5.3%
Credit Services
Personal Credit Institutions
Link
United States
NEWARK